Filing Details
- Accession Number:
- 0001209191-21-003807
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-15 16:30:23
- Reporting Period:
- 2021-01-13
- Accepted Time:
- 2021-01-15 16:30:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 818033 | Heron Therapeutics Inc. | HRTX | Pharmaceutical Preparations (2834) | 942875566 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1602459 | Leslie David Szekeres | 4242 Campus Point Court Suite 200 San Diego CA 92121 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-13 | 1,250 | $0.00 | 1,250 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-13 | 423 | $18.16 | 827 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-01-14 | 827 | $18.09 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2021-01-13 | 1,250 | $0.00 | 1,250 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,750 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert into common stock on a one-for-one basis.
- Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
- The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of November 30, 2020.
- The range of sales prices received was $17.71 to $18.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020).
Billionaire Hedge Funds
